Biogen Inc.BIIBNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, below historical average, slight contraction.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$3.00B
↓ 42% below average
Average (9y)
$5.13B
Historical baseline
Range
High:$7.74B
Low:$2.38B
CAGR
-6.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $3.00B | +26.0% |
| 2023 | $2.38B | -32.8% |
| 2022 | $3.54B | -9.9% |
| 2021 | $3.92B | -23.2% |
| 2020 | $5.11B | -34.0% |
| 2019 | $7.74B | +10.3% |
| 2018 | $7.01B | +6.2% |
| 2017 | $6.61B | +4.1% |
| 2016 | $6.35B | +13.0% |
| 2015 | $5.62B | - |